In addition to the shock of a cancer diagnosis and stress of treatment, cancer patients  may also be at higher risk of severe illness from COVID-19 because their cancer, or its treatment, has left them more vulnerable to complications.

The National Cancer Institute (NCI) launched a long-term, nationwide study of COVID-19 in people with cancer called NCI COVID-19 in Cancer Patients Study (NCCAPS).

In this podcast episode, NCCS CEO Shelley Fuld Nasso speaks with leaders of the study] about how it will help scientists answer key questions about COVID-19’s impact on cancer patients, as well as cancer’s impact on the course of COVID-19. The findings have the potential to influence the treatment of cancer patients with COVID-19 in the future.